chr16-30985729-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_025193.4(HSD3B7):​c.71A>G​(p.His24Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0025 in 1,608,688 control chromosomes in the GnomAD database, including 122 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H24Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0015 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0026 ( 116 hom. )

Consequence

HSD3B7
NM_025193.4 missense

Scores

1
9
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.13
Variant links:
Genes affected
HSD3B7 (HGNC:18324): (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7) This gene encodes an enzyme which is involved in the initial stages of the synthesis of bile acids from cholesterol and a member of the short-chain dehydrogenase/reductase superfamily. The encoded protein is a membrane-associated endoplasmic reticulum protein which is active against 7-alpha hydrosylated sterol substrates. Mutations in this gene are associated with a congenital bile acid synthesis defect which leads to neonatal cholestasis, a form of progressive liver disease. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0062257946).
BP6
Variant 16-30985729-A-G is Benign according to our data. Variant chr16-30985729-A-G is described in ClinVar as [Benign]. Clinvar id is 284323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-30985729-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00152 (232/152382) while in subpopulation SAS AF = 0.0466 (225/4832). AF 95% confidence interval is 0.0416. There are 6 homozygotes in GnomAd4. There are 160 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSD3B7NM_025193.4 linkc.71A>G p.His24Arg missense_variant Exon 2 of 7 ENST00000297679.10 NP_079469.2 Q9H2F3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HSD3B7ENST00000297679.10 linkc.71A>G p.His24Arg missense_variant Exon 2 of 7 1 NM_025193.4 ENSP00000297679.5 Q9H2F3-1

Frequencies

GnomAD3 genomes
AF:
0.00153
AC:
233
AN:
152264
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0467
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00519
AC:
1238
AN:
238478
AF XY:
0.00706
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000296
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000467
Gnomad OTH exome
AF:
0.00205
GnomAD4 exome
AF:
0.00260
AC:
3788
AN:
1456306
Hom.:
116
Cov.:
33
AF XY:
0.00379
AC XY:
2742
AN XY:
724224
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33392
American (AMR)
AF:
0.0000678
AC:
3
AN:
44250
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25990
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39644
South Asian (SAS)
AF:
0.0422
AC:
3604
AN:
85318
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52170
Middle Eastern (MID)
AF:
0.00157
AC:
7
AN:
4468
European-Non Finnish (NFE)
AF:
0.0000324
AC:
36
AN:
1110954
Other (OTH)
AF:
0.00220
AC:
132
AN:
60120
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
268
536
805
1073
1341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00152
AC:
232
AN:
152382
Hom.:
6
Cov.:
33
AF XY:
0.00215
AC XY:
160
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.0000721
AC:
3
AN:
41600
American (AMR)
AF:
0.0000653
AC:
1
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.0466
AC:
225
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68040
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
12
24
35
47
59
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000555
Hom.:
1
Bravo
AF:
0.000348
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00598
AC:
726
Asia WGS
AF:
0.0170
AC:
60
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Oct 30, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.090
CADD
Benign
22
DANN
Benign
0.96
DEOGEN2
Uncertain
0.67
.;D;D;.
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.89
D;D;T;D
MetaRNN
Benign
0.0062
T;T;T;T
MetaSVM
Uncertain
0.38
D
MutationAssessor
Benign
1.8
L;L;.;.
PhyloP100
2.1
PrimateAI
Uncertain
0.74
T
PROVEAN
Uncertain
-2.6
D;D;.;.
REVEL
Pathogenic
0.67
Sift
Benign
0.20
T;T;.;.
Sift4G
Benign
0.60
T;T;T;T
Polyphen
0.99
.;D;.;.
Vest4
0.67
MVP
0.92
MPC
0.92
ClinPred
0.054
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.53
gMVP
0.89
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Loading publications...

Other links and lift over

dbSNP: rs201796375; hg19: chr16-30997050; COSMIC: COSV52682011; COSMIC: COSV52682011; API